Related Experiment Video
Updated: Mar 24, 2026

Working with Auditory HEI-OC1 Cells
Published on: September 3, 2016
HEI-OC1 cells as a model for investigating drug cytotoxicity
Gilda Kalinec1, Pru Thein1, Channy Park1
1Laboratory of Auditory Cell Biology, Department of Head & Neck Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Abstract:
The House Ear Institute-Organ of Corti 1 (HEI-OC1) is one of the few, and arguable the most used, mouse auditory cell line available for research purposes. Originally proposed as an in vitro system for screening of ototoxic drugs, it has been used to investigate, among other topics, apoptotic pathways, autophagy and senescence, mechanism of cell protection, inflammatory responses, cell differentiation, effects of hypoxia, oxidative and endoplasmic reticulum stress, and expression of molecular channels and receptors. However, the use of different techniques with different goals resulted in apparent contradictions on the actual response of these cells to some specific treatments. We have now performed studies to characterize the actual response of HEI-OC1 cells to a battery of commonly used pharmacological drugs. We evaluated cell toxicity, apoptosis, viability, proliferation, senescence and autophagy in response to APAP (acetaminophen), cisplatin, dexamethasone, gentamicin, penicillin, neomycin, streptomycin, and tobramycin, at five different doses and two time-points (24 and 48 h), by flow cytometry techniques and caspase 3/7, MTT, Cytotoxicity, BrdU, Beclin1, LC3 and SA-β-galactosidase assays. We also used HEK-293 and HeLa cells to compare some of the responses of these cells to those of HEI-OC1. Our results indicate that every cell line responds to the each drug in a different way, with HEI-OC1 cells showing a distinctive sensitivity to at least one of the mechanisms under study. Altogether, our results suggest that the HEI-OC1 might be a useful model to investigate biological responses associated with auditory cells, including auditory sensory cells, but a careful approach would be necessary at the time of evaluating drug effects.
Insights
The House Ear Institute-Organ of Corti 1 (HEI-OC1) mouse auditory cell line shows unique drug responses. Researchers must carefully evaluate drug effects on these cells for accurate auditory research.
Area of Science:
- Oto-pharmacology
- Cellular Biology
- Auditory Research
Background:
- The House Ear Institute-Organ of Corti 1 (HEI-OC1) is a widely used mouse auditory cell line for in vitro research.
- Previous studies using HEI-OC1 cells have yielded contradictory results due to varied methodologies.
- This study aims to clarify HEI-OC1 cell responses to common pharmacological agents.
Purpose of the Study:
- To characterize the precise responses of HEI-OC1 cells to a panel of frequently used drugs.
- To assess cell toxicity, apoptosis, viability, proliferation, senescence, and autophagy.
- To compare HEI-OC1 responses with HEK-293 and HeLa cells.
Main Methods:
- HEI-OC1 cells were treated with acetaminophen (APAP), cisplatin, dexamethasone, gentamicin, penicillin, neomycin, streptomycin, and tobramycin.
- Evaluations were conducted at five doses and two time-points (24 and 48 hours).
- Assays included flow cytometry, caspase 3/7, MTT, Cytotoxicity, BrdU, Beclin1, LC3, and SA-β-galactosidase.
Main Results:
- HEI-OC1 cells exhibited distinct sensitivities to specific drugs and mechanisms.
- Responses varied significantly across different cell lines (HEI-OC1, HEK-293, HeLa) for each drug.
- Drug effects on apoptosis, senescence, and autophagy pathways were dose- and time-dependent.
Conclusions:
- HEI-OC1 cells present a unique pharmacological profile, making them a valuable model for auditory cell research.
- Careful consideration of drug effects and cell-specific responses is crucial when using HEI-OC1 cells.
- Standardized protocols are recommended for consistent and reliable results in auditory drug screening.
More Related Videos
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
11:38High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
Published on: May 10, 2016